Quarterly report · Q3
9158.TEDINET S100STWG
Period2023-04-01 → 2023-12-31
Filed2024-02-09
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥23.4bn | 2023-04-01 → 2023-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥8.0bn | 2023-10-01 → 2023-12-31d | Cons. | Revenue IFRS |
| Revenue | ¥35.2bn | 2022-04-01 → 2023-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥27.4bn | 2022-04-01 → 2022-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥8.8bn | 2022-10-01 → 2022-12-31d | Cons. | Revenue IFRS |
| Operating income | ¥2.6bn | 2023-04-01 → 2023-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥842m | 2023-10-01 → 2023-12-31d | Cons. | Operating profit loss IFRS |
| Operating income | ¥3.2bn | 2022-04-01 → 2022-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥863m | 2022-10-01 → 2022-12-31d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥2.4bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥751m | 2023-10-01 → 2023-12-31d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥3.6bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥3.1bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥857m | 2022-10-01 → 2022-12-31d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥1.5bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥461m | 2023-10-01 → 2023-12-31d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥2.4bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥2.1bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥634m | 2022-10-01 → 2022-12-31d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥1.5bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥459m | 2023-10-01 → 2023-12-31d | Cons. | Profit loss IFRS |
| Net income | ¥2.1bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥630m | 2022-10-01 → 2022-12-31d | Cons. | Profit loss IFRS |
| Total assets | ¥58.0bn | at 2023-12-31 | Cons. | Assets IFRS |
| Total assets | ¥39.8bn | at 2023-03-31 | Cons. | Assets IFRS |
| Total assets | ¥37.5bn | at 2022-12-31 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥31.7bn | at 2023-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥27.8bn | at 2023-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥26.3bn | at 2023-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥11.9bn | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥11.5bn | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥9.7bn | at 2022-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥26.1bn | at 2023-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥11.7bn | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥11.3bn | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥17.5bn | at 2023-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥4.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥4.5bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥4.4bn | at 2022-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥2.5bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥2.4bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | −¥408m | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥4.3bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥6.7bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥2.6bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥15.2bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥4.0bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥3.0bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥55.45 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥15.73 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥113.9 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥101.86 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥29.6 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥55.45 | 2023-04-01 → 2023-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥15.73 | 2023-10-01 → 2023-12-31d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥113.9 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥101.86 | 2022-04-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥29.6 | 2022-10-01 → 2022-12-31d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 44.9% | at 2023-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 29.4% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 30.2% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 98
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-12-31 | ¥148m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-10-01 → 2023-12-31 | ¥50m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-12-31 | ¥148m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-10-01 → 2023-12-31 | ¥50m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-12-31 | ¥13m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-10-01 → 2023-12-31 | ¥9m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-12-31 | −¥477m |
| Reconciling Itemsreconciling | revenue | 2023-10-01 → 2023-12-31 | −¥188m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-12-31 | −¥477m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-10-01 → 2023-12-31 | −¥188m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-12-31 | −¥874m |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2023-12-31 | −¥298m |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥7.5bn |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | revenue | 2023-10-01 → 2023-12-31 | ¥2.7bn |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥7.5bn |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | revenue external | 2023-10-01 → 2023-12-31 | ¥2.7bn |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥0 |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | revenue intersegment | 2023-10-01 → 2023-12-31 | ¥0 |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥142m |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | segment profit | 2023-10-01 → 2023-12-31 | ¥205m |
| jpcrp040300-q3r_E37214-000In Home Nursingreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥8.3bn |
| jpcrp040300-q3r_E37214-000In Home Nursingreportable segment | revenue | 2023-10-01 → 2023-12-31 | ¥2.7bn |
| jpcrp040300-q3r_E37214-000In Home Nursingreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥8.3bn |
| jpcrp040300-q3r_E37214-000In Home Nursingreportable segment | revenue external | 2023-10-01 → 2023-12-31 | ¥2.7bn |
| jpcrp040300-q3r_E37214-000In Home Nursingreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥497m |
| jpcrp040300-q3r_E37214-000In Home Nursingreportable segment | segment profit | 2023-10-01 → 2023-12-31 | ¥111m |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥8.0bn |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | revenue | 2023-10-01 → 2023-12-31 | ¥2.7bn |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥7.5bn |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | revenue external | 2023-10-01 → 2023-12-31 | ¥2.5bn |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥477m |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | revenue intersegment | 2023-10-01 → 2023-12-31 | ¥187m |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥2.8bn |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | segment profit | 2023-10-01 → 2023-12-31 | ¥815m |
| —segment total | revenue | 2023-04-01 → 2023-12-31 | ¥23.7bn |
| —segment total | revenue | 2023-10-01 → 2023-12-31 | ¥8.2bn |
| —segment total | revenue external | 2023-04-01 → 2023-12-31 | ¥23.2bn |
| —segment total | revenue external | 2023-10-01 → 2023-12-31 | ¥8.0bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥477m |
| —segment total | revenue intersegment | 2023-10-01 → 2023-12-31 | ¥188m |
| —segment total | segment profit | 2023-04-01 → 2023-12-31 | ¥3.5bn |
| —segment total | segment profit | 2023-10-01 → 2023-12-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-12-31 | ¥23.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-10-01 → 2023-12-31 | ¥8.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-12-31 | ¥23.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-10-01 → 2023-12-31 | ¥8.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥477m |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-10-01 → 2023-12-31 | ¥188m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-12-31 | ¥3.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-10-01 → 2023-12-31 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-12-31 | ¥147m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-10-01 → 2022-12-31 | ¥48m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-12-31 | ¥147m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-10-01 → 2022-12-31 | ¥48m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-12-31 | ¥18m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-10-01 → 2022-12-31 | ¥10m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥178m |
| Reconciling Itemsreconciling | revenue | 2022-10-01 → 2022-12-31 | −¥70m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥178m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-10-01 → 2022-12-31 | −¥70m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥604m |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2022-12-31 | −¥218m |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥4.6bn |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥1.6bn |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥4.6bn |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥1.6bn |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥253m |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | segment profit | 2022-10-01 → 2022-12-31 | ¥57m |
| jpcrp040300-q3r_E37214-000In Home Nursingreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥9.3bn |
| jpcrp040300-q3r_E37214-000In Home Nursingreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥2.8bn |
| jpcrp040300-q3r_E37214-000In Home Nursingreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥9.3bn |
| jpcrp040300-q3r_E37214-000In Home Nursingreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥2.8bn |
| jpcrp040300-q3r_E37214-000In Home Nursingreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.1bn |
| jpcrp040300-q3r_E37214-000In Home Nursingreportable segment | segment profit | 2022-10-01 → 2022-12-31 | ¥264m |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥13.6bn |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥4.3bn |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥13.4bn |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥4.2bn |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥178m |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥70m |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥2.4bn |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | segment profit | 2022-10-01 → 2022-12-31 | ¥749m |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥27.5bn |
| —segment total | revenue | 2022-10-01 → 2022-12-31 | ¥8.8bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥27.3bn |
| —segment total | revenue external | 2022-10-01 → 2022-12-31 | ¥8.7bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥178m |
| —segment total | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥70m |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥3.8bn |
| —segment total | segment profit | 2022-10-01 → 2022-12-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥27.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-10-01 → 2022-12-31 | ¥8.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥27.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-10-01 → 2022-12-31 | ¥8.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥178m |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥70m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥3.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-10-01 → 2022-12-31 | ¥1.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 945
| Item | Context | Value | Unit |
|---|---|---|---|
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所グロース市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)完全議決権株式であり、権利内容に何ら限定のない当社における標準となる株式です。なお、単元株式数は100株です。 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)株式会社シーユーシー | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)東京都港区芝浦三丁目１番１号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Description of fact that consolidated financial statements have been prepared in accordance with IFRS financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Condensed quarterly consolidated statement of financial position IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Condensed year to quarter end consolidated statement of profit or loss IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Condensed quarter period consolidated statement of profit or loss IFRS (text) | CurrentQuarterDuration | Text · Plus | |
| Condensed year to quarter end consolidated statement of comprehensive income IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Condensed quarter period consolidated statement of comprehensive income IFRS (text) | CurrentQuarterDuration | Text · Plus | |
| Condensed quarterly consolidated statement of changes in equity IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Condensed quarterly consolidated statement of cash flows IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes reporting entity condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes basis of preparation condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant accounting policies condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant accounting estimates and judgements condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Disclosure of changes in reportable segments IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes business combinations condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes borrowings condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes share capital and other equity items condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes dividends condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes earnings per share condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes fair value of financial instruments condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes related parties condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Notes subsequent events condensed quarterly consolidated financial statements IFRS (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |